Merck宣布了新兴生物技术赠款方案的获奖者,以帮助亚太生物技术新创办企业。 Merck announced winners of its Emerging Biotech Grant Program to aid Asia Pacific biotech startups.

Merck宣布了亚太地区新兴生物技术赠款方案的获奖者,该方案旨在支持生物技术创业企业更有效地发展治疗技术。 Merck has announced the winners of its Emerging Biotech Grant Program in the Asia Pacific region, aimed at supporting biotech startups in developing therapeutics more efficiently. 该方案已扩大到包括澳大利亚、新西兰、台湾和南朝鲜,它提供实物技术和专家协商,帮助应对药物开发方面持续存在的挑战。 The program, which has expanded to include Australia, New Zealand, Taiwan, and South Korea, provides in-kind technologies and expert consultations to help address ongoing challenges in drug development. 自2014年启动以来,该方案在全球支持了40多个公司,重点是改善各种疾病的患者结果。 Since its launch in 2014, the program has supported over 40 companies globally, focusing on improving patient outcomes for various diseases.